Filing Details

Accession Number:
0001171843-17-007021
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-14 17:05:38
Reporting Period:
2017-11-14
Accepted Time:
2017-11-14 17:05:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1359931 Proteon Therapeutics Inc PRTO Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1622905 Eldridge, George Arthur C/O Proteon Therapeutics
200 West Street
Waltham MA 02451
Sr Vp, Cfo, Treasr, Asst Secy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-14 295 $1.69 1,545 No 5 P Indirect As custodian for child's UTMA account
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Indirect As custodian for child's UTMA account
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,750 Direct
Footnotes
  1. These securities were purchased by the reporting person as custodian for three minor children under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.